Chronic fatigue syndrome (CFS), also known as myalgia encephalomyelitis (ME/CFS), is a complex and disabling illness marked by persistent, unexplained fatigue and a range of symptoms including musculoskeletal pain, sleep disturbances, headaches, difficulty concentrating, and impaired short-term memory. These symptoms significantly reduce quality of life and daily functioning. Current estimates suggest CFS may affect more people than previously recognized, with prevalence figures higher than earlier estimates.
Clinical guidelines commonly recommend exercise therapy as part of a comprehensive treatment strategy for CFS. Early reviews, including a 2004 Cochrane review, highlighted the potential benefits of structured physical activity for people with CFS while calling for more robust evidence on safety and effectiveness.
A more recent systematic review of the evidence examined randomized controlled trials involving adults diagnosed with CFS. These studies typically compared structured exercise interventions with a range of control conditions such as usual care, relaxation techniques, cognitive behavioral therapy (CBT), supportive listening, pacing (an activity management approach), or medications. Exercise therapy in these trials often took the form of graded exercise programs, where participants start with manageable levels of activity and gradually increase intensity or duration over time.
With multiple trials involving over 1,500 participants, exercise therapy was generally associated with improvements in key outcomes:
Importantly, no serious adverse events were consistently reported in these trials, although differences in outcome measurement tools made comparison across studies challenging. For example, one study showed an average reduction in fatigue scores of around 6 points on an 11-point scale after treatment. Interventions ranged from roughly three to six months in duration.
The exercise programs studied varied, but most followed a graded approach where participants begin at a level of physical activity they can achieve without undue strain, then progressively increase the dose of exercise in negotiation with clinicians. This method is designed to build tolerance and avoid symptom spikes.
While results generally support the potential benefits of exercise therapy for CFS, some guidelines and patient groups highlight safety concerns, particularly regarding post-exertional malaise (PEM), a hallmark CFS symptom in which symptoms worsen after even modest physical or mental activity. Some health authorities have questioned the universal applicability of graded exercise programs, recommending individualized activity management approaches to avoid overexertion.
Exercise therapy, especially when tailored and progressively structured, appears to offer meaningful benefits for many people with CFS, including reduced fatigue, better sleep, improved physical functioning, and greater self-reported health. However, individual responses vary, and clinicians typically emphasize careful monitoring, personalized goals, and adjustments based on each person’s symptoms and tolerance.
Sources:
Reeves W, Jones J, Maloney E, et al. Prevalence of chronic fatigue syndrome in metropolitan, urban, rural, Georgia. Popul Health Metr. 5:5.
Larun L, Bruberg K, Odgaard-Jensen J, Price J. Exercise therapy for chronic fatigue syndrome. Cochrane Database Syst Rev. (2): CD003200.
Print
PDF
